A.R.T. Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

A.R.T. Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-120,662	Closed	-$567K	–	1176
2019 Q4	$567K	Buy	120,662 +69,100	+134%	+$283K	0.03%	796
2019 Q3	$172K	Buy	+51,562	New	+$170K	0.01%	1201
2019 Q2	–	Sell	-94,162	Closed	-$285K	–	1735
2019 Q1	$285K	Sell	94,162 -6,832	-7%	-$22.1K	0.02%	955
2018 Q4	$275K	Buy	100,994 +42,300	+72%	+$139K	0.02%	955
2018 Q3	$197K	Sell	58,694 -60,100	-51%	-$186K	0.01%	1197
2018 Q2	$306K	Buy	118,794 +20,991	+21%	+$52.2K	0.01%	1103
2018 Q1	$215K	Sell	97,803 -91,824	-48%	-$207K	0.01%	1244
2017 Q4	$377K	Buy	189,627 +175,613	+1,253%	+$382K	0.02%	1000
2017 Q3	$45K	Buy	+14,014	New	+$43.2K	﹤0.01%	1263
2017 Q2	–	Sell	-166,414	Closed	-$472K	–	1828
2017 Q1	$472K	Buy	+166,414	New	+$400K	0.02%	836
2016 Q1	–	Sell	-16,087	Closed	-$19K	–	1741
2015 Q4	$19K	Buy	+16,087	New	+$22.4K	﹤0.01%	1414
2015 Q1	–	Sell	-12,497	Closed	-$32K	–	1780
2014 Q4	$32K	Sell	12,497 -53,368	-81%	-$120K	﹤0.01%	1366
2014 Q3	$120K	Buy	65,865 +10,343	+19%	+$22.6K	0.01%	1184
2014 Q2	$148K	Buy	55,522 +17,200	+45%	+$51.8K	0.01%	1184
2014 Q1	$134K	Buy	+38,322	New	+$170K	0.01%	1209

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

A.R.T. Advisors's ATRS Position: Q1 2020 in Review

A.R.T. Advisors sold out of Antares Pharma, Inc. (ATRS) in Q1 2020, closing a stake of 120,662 shares — an estimated $567K sold.

A.R.T. Advisors first reported a position in ATRS in Q1 2014 and held it in 15 quarters. The position peaked at $567K in Q4 2019. 154 funds tracked by Wall St. Rank hold ATRS as of Q1 2020.

A.R.T. Advisors reported no remaining Antares Pharma, Inc. position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 120,662 Antares Pharma, Inc. shares in Q1 2020, an estimated $567K.
A.R.T. Advisors first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 15 quarters.
A.R.T. Advisors's Antares Pharma, Inc. position peaked at $567K in Q4 2019.
154 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.